Oryon Cell Therapies
PrivateLast Round
Series A
Mar 23, 2026
Total Funding Raised
$42M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Oryon Cell Therapies is a biotechnology company that develops autologous cell therapies for neurodegenerative disorders, with an initial focus on Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oryon Cell Therapies Comparables
Compare Oryon Cell Therapies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aspen Neuroscience | 88% | |
| Shanghai UniXell Biotechnology | 88% | |
| Kenai Therapeutics | 86% |
Oryon Cell Therapies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 23, 2026 |
Key People
Founding team and executive leadership
Oryon Cell Therapies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Byers Capital | Series A |
| Neuro.VC | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 23, 2026
$21M round completed.
Recent news
Latest coverage and updates
- hiresAug 27, 2026
Oryon Cell Therapies hired Choi as Chief Technical Officer on Aug 27th '26.
- hiresAug 27, 2026
Oryon Cell Therapies hired Kenny as Chief Technical Officer on Aug 27th '26.
Oryon Cell Therapies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Oryon Cell Therapies's valuation, stock price, and market status.
Is Oryon Cell Therapies a public or private company?
Oryon Cell Therapies is a private company.
What is the current stock price of Oryon Cell Therapies?
Oryon Cell Therapies is a private company with no public stock price. No recent secondary market data is available.
How much is Oryon Cell Therapies worth (valuation)?
Valuation information for Oryon Cell Therapies is not publicly available.
Can I buy Oryon Cell Therapies stock?
Oryon Cell Therapies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Oryon Cell Therapies's last funding round?
Oryon Cell Therapies's most recent funding round was Series A on March 23, 2026.
Who are the main investors in Oryon Cell Therapies?
Key investors in Oryon Cell Therapies include Byers Capital, Neuro.VC.
Will Oryon Cell Therapies IPO soon?
No public IPO plans have been announced for Oryon Cell Therapies.
How can I track Oryon Cell Therapies secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Oryon Cell Therapies's secondary market activity and sign up for updates.